Article Details

FDA to Review a Preventative RSV Treatment Developed for Infant Population

Retrieved on: 2023-01-05 20:04:53

Tags for this article:

Click the tags to see associated articles and topics

FDA to Review a Preventative RSV Treatment Developed for Infant Population. View article details on HISWAI: https://www.pharmacytimes.com/view/fda-to-review-a-preventative-rsv-treatment-developed-for-infant-population

Excerpt

The FDA accepted the biologics license application (BLA) for nirsevimab (Beyfortus; AstraZeneca), which is an antibody indicated to prevent ...

Article found on: www.pharmacytimes.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up